1832 Asset Management L.P. Catalent, Inc. Transaction History

1832 Asset Management L.P.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$42.56 - $59.82 $2,808 - $3,948	66 New	66 $3,000
Q1 2023 May 12, 2023	SELL	$45.44 - $74.26 $14.2 Million - $23.2 Million	-311,858 Reduced 99.43%	1,800 $118,000
Q4 2022 Feb 14, 2023	SELL	$41.39 - $81.0 $1.27 Million - $2.49 Million	-30,700 Reduced 8.92%	313,658 $14.1 Million
Q3 2022 Nov 14, 2022	BUY	$72.36 - $113.1 $17.6 Million - $27.6 Million	243,598 Added 241.76%	344,358 $24.9 Million
Q2 2022 Aug 15, 2022	SELL	$87.2 - $114.05 $11.3 Million - $14.8 Million	-129,695 Reduced 56.28%	100,760 $10.8 Million
Q1 2022 May 16, 2022	BUY	$94.19 - $124.49 $21.7 Million - $28.7 Million	230,455 New	230,455 $25.2 Million
Q4 2021 Feb 15, 2022	SELL	$119.57 - $139.07 $145,277 - $168,970	-1,215 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$109.17 - $142.35 $132,641 - $172,955	1,215 New	1,215 $164,000
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $11 Million - $13.6 Million	-108,400 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $9.31 Million - $11.4 Million	108,400 New	108,400 $11.2 Million

344

137M

571K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

Stay updated on 1832 Asset Management L.P. with notifications on news.